CHU Bichat, Paris
Ferumoxtran-10-enhanced MRI can quantify aortic macrophage infiltration
Published in Health Insurance Week, February 26th, 2006
"Ferumoxtran-10 is an MRI contrast agent, which accumulates in macrophages and induces magnetic susceptibility artifacts (MSAs)," according to cardiologists in France, who "evaluated the ability of ferumoxtran-10-enhanced MRI to quantify focal macrophage infiltration in the aortic wall of hypercholesterolemic rabbits."
"Six weeks after a double-balloon injury of the infrarenal aorta, 12 hypercholesterolemic rabbits underwent MRI of the aorta before (first MRI) and after (second MRI) intravenous injection of ferumoxtran-10...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
More Articles from Health Insurance Week
- Health Management Associates, Inc.
Nonurban hospitals operator reports Q1 earnings; net patient service revenue grew 14.9% - Acacia Research Corp.
Biological arrays maker expands alliance with Inbio - Astellas Pharma
FK614, a novel PPAR gamma modulator, has potential antidiabetic properties - Ben Gurion University of Negev, Beer Sheva
Low-level laser irradiation stimulates osteogenic MSC phenotype seeded on 3D biomatrix - BioSphere Medical, Inc.
Uterine fibroid treatment developer reports 20% revenue growth - CHU Vaudois, Lausanne
Macrophage migration inhibitory factor promotes innate immune responses - More from this issue of Health Insurance Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
